<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.7643.3.1051" displayName="Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="1045402" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="dasatinib 140 MG Oral Tablet"/>            <ns0:Concept code="1045406" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="dasatinib 80 MG Oral Tablet"/>            <ns0:Concept code="1307624" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="bosutinib 100 MG Oral Tablet"/>            <ns0:Concept code="1307633" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="bosutinib 500 MG Oral Tablet"/>            <ns0:Concept code="1364352" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="ponatinib 15 MG Oral Tablet"/>            <ns0:Concept code="1364360" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="ponatinib 45 MG Oral Tablet"/>            <ns0:Concept code="1726637" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="ponatinib 30 MG Oral Tablet"/>            <ns0:Concept code="1987732" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="bosutinib 400 MG Oral Tablet"/>            <ns0:Concept code="2002717" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="nilotinib 50 MG Oral Capsule"/>            <ns0:Concept code="403878" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="imatinib 100 MG Oral Tablet"/>            <ns0:Concept code="403879" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="imatinib 400 MG Oral Tablet"/>            <ns0:Concept code="643105" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="dasatinib 20 MG Oral Tablet"/>            <ns0:Concept code="643107" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="dasatinib 50 MG Oral Tablet"/>            <ns0:Concept code="643109" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="dasatinib 70 MG Oral Tablet"/>            <ns0:Concept code="746606" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="nilotinib 200 MG Oral Capsule"/>            <ns0:Concept code="799047" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="dasatinib 100 MG Oral Tablet"/>            <ns0:Concept code="997653" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="nilotinib 150 MG Oral Capsule"/>        </ns0:ConceptList>        <ns0:Source>Oncology Nursing Society </ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains RxNORM codes associated with tyrosine kinase inhibitors (TKIs) commonly used to treat patients with chronic myeloid leukemia.),(Data Element Scope: This would use the Medication QDM category.),(Inclusion Criteria: The following generic, prescribable TKIs are included in this value set: bosutinib, dasatinib, imatinib, nilotinib, ponatinib.),(Exclusion Criteria: TKIs not listed above are excluded from this value set, including brand name drugs or brand name drug packs.)</ns0:Purpose>        <ns0:Definition>(2.16.840.1.113883.3.7643.2.1049:Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia)</ns0:Definition>        <ns0:Type>Grouping</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2019-01-08</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>